US Broker Ratings

Exact Sciences Corporation (EXAS) Stock Analysis: Steady Growth in Diagnostics Sector with 3.39% Potential Upside

Exact Sciences Corporation (NASDAQ: EXAS), a leader in the diagnostics and research sector, has attracted significant investor attention as its current stock price hovers at $102.34, nearing the upper end..

AstraZeneca PLC (AZN) Stock Analysis: Unpacking a 9.71% Potential Upside in the Healthcare Giant

AstraZeneca PLC (NASDAQ: AZN), a colossus in the global biopharmaceutical landscape, continues to captivate investors with its solid performance and strategic collaborations. With a market capitalization of $287.64 billion, AstraZeneca..

The Ensign Group, Inc. (ENSG) Stock Analysis: Robust Growth and a 21% Potential Upside

The Ensign Group, Inc. (NASDAQ: ENSG) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $9.94 billion, the company..

ResMed Inc. (RMD) Stock Analysis: A Strong Performer with 15% Upside Potential

ResMed Inc. (NYSE: RMD) is a major player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $37.7 billion, the company has..

Repligen Corporation (RGEN) Stock Analysis: Navigating a 27.80% Potential Upside in the Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN) is garnering significant attention in the healthcare sector, specifically within the medical instruments and supplies industry. The company, headquartered in Waltham, Massachusetts, focuses on developing and..

TransMedics Group, Inc. (TMDX) Stock Analysis: Exploring Growth Potential Amidst Robust Revenue Surge in Medical Devices

TransMedics Group, Inc. (NASDAQ: TMDX), a leader in the medical devices sector, is capturing the interest of investors with its innovative approach to organ transplant therapy. With a market capitalization..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Tapping into a 43% Potential Upside in the Healthcare Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC) is making waves in the healthcare sector with its innovative approach to cardiac monitoring. Based in San Francisco, this medical device company has carved out..

Exelixis, Inc. (EXEL) Stock Analysis: Insights on Growth Potential and Market Position

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, is making waves with its focus on developing innovative oncology treatments. With a market capitalization of $11.13 billion, Exelixis..

Alkermes plc (ALKS) Stock Analysis: Navigating a 29% Potential Upside in the Biopharmaceutical Sector

Alkermes plc (NASDAQ: ALKS) stands out as a noteworthy player in the healthcare arena, specializing in the development and commercialization of pharmaceutical products that address significant unmet medical needs. Headquartered..

Natera, Inc. (NTRA) Stock Analysis: Potential Growth Amidst Strong Analyst Confidence

Natera, Inc. (NASDAQ: NTRA), a prominent player in the diagnostics and research industry, is drawing significant attention in the healthcare sector. With a market capitalization of $32.23 billion, the company..

Legend Biotech Corporation (LEGN): Investor Outlook with a 278% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN) is captivating the attention of investors, particularly those with an appetite for risk and a focus on the healthcare sector. With a potential upside of..

Jazz Pharmaceuticals plc (JAZZ): Investor Outlook with a 32% Potential Upside and Strong Buy Ratings

Investors seeking promising opportunities in the biotech sector may find Jazz Pharmaceuticals plc (NASDAQ: JAZZ) particularly intriguing, given its robust product lineup and attractive valuation metrics. With a current market..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring an 84% Potential Upside

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, is drawing investor attention with its compelling growth potential. Operating within the Medical Instruments & Supplies industry, this..

BioMarin Pharmaceutical Inc. (BMRN): Investor Outlook on a Biotech Leader with 60% Upside Potential

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is a prominent player in the biotechnology sector, specializing in the development and commercialization of therapies for life-threatening rare diseases. Based in San Rafael, California,..

DaVita Inc. (DVA) Stock Analysis: A 30.78% Upside Potential in the Healthcare Sector

DaVita Inc. (NYSE: DVA), a leading provider in the healthcare industry, particularly in medical care facilities, has piqued investor interest with a potential upside of 30.78%. This Denver-based company specializes..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: A Compelling 34% Upside Potential in the Biotech Space

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company specializing in therapies for metabolic dysfunction-associated steatohepatitis (MASH), has captured the attention of investors with its impressive growth potential and robust market..

Option Care Health, Inc. (OPCH) Stock Analysis: A 17% Potential Upside with Strong Buy Ratings

For investors looking to tap into the burgeoning healthcare sector, Option Care Health, Inc. (NASDAQ: OPCH) presents an intriguing opportunity. This Bannockburn, Illinois-based company is a prominent player in the..

DexCom, Inc. (DXCM) Stock Analysis: Exploring a 16.64% Upside Potential in the Growing Medical Devices Sector

DexCom, Inc. (DXCM) stands at the forefront of innovation in the healthcare sector, specifically within the medical devices industry. Headquartered in San Diego, California, DexCom is renowned for its cutting-edge..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a Potential 90.61% Upside for Investors

Vaxcyte, Inc. (NASDAQ: PCVX), a prominent player in the biotechnology sector, is making significant waves with its innovative approach to vaccine development. Based in San Carlos, California, Vaxcyte focuses on..

Globus Medical, Inc. (GMED): Analyst Consensus and Growth Potential Highlight an 18% Upside

Globus Medical, Inc. (NYSE: GMED) stands out in the healthcare sector, particularly within the medical devices industry, as a company that continues to capture investor attention with robust growth prospects..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds